Draupnir raises size of PolyPeptide block due to high demand

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Draupnir raises size of PolyPeptide block due to high demand

Stunning view of the Jungfrau and mountain range of Bernese alps from Mannlichen cablecar station, Switzerland.
G0R1B4 Stunning view of the Jungfrau and mountain range of Bernese alps from Mannlichen cablecar station, Switzerland. | Alamy Stock Photo

The majority shareholders of the Swiss pharma chemicals firm sold Sfr171 of shares at the end of the post-IPO lockup

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article